SEC Form 4 · accession 0001209191-18-058825
Eton Pharmaceuticals, Inc. · ETON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul V Maier
Director
Period of report
Nov 15, 2018
Accepted (ET)
Nov 15, 2018 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001710340
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2018 | P | 5,000 | $6.00 | A | 59,745 | D |
Table II — derivative securities
No Table II lines on this filing.